𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Riluzole in Huntington's disease (HD): an open label study with one year follow up

✍ Scribed by Klaus Seppi; Joerg Mueller; Thomas Bodner; Elisabeth Brandauer; Thomas Benke; Helga Weirich-Schwaiger; Werner Poewe; Gregor K. Wenning

Publisher
Springer
Year
2001
Tongue
English
Weight
163 KB
Volume
248
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Accuracy of DaTSCAN (123I-ioflupane) SPE
Accuracy of DaTSCAN (123I-ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-Year follow-up of an open-label study
✍ Eduardo Tolosa; Thierry Vander Borght; Emilio Moreno 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

## Abstract We previously reported on the role of dopamine transporter (DAT) SPECT in the workup of patients with clinically uncertain parkinsonian syndromes (CUPS). The findings of that study supported the use of SPECT imaging with DaTSCAN (^123^I‐Ioflupane) for accurate diagnosis in this populati

Efficacy and safety of donepezil over 3
Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease
✍ A. Burns; S. Gauthier; C. Perdomo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective This 132‐week, open‐label extension study assessed the long‐term efficacy and safety of donepezil in 579 patients with mild to moderate Alzheimer's disease (AD) who had previously participated in a 24‐week double‐blind study of 5 or 10 mg/day donepezil __vs__ placebo. ##